Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients

Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients

Bibliographic Details
Main Authors: Bousquet, G, Alexandre, J, Le Tourneau, C, Goldwasser, F, Faivre, S, de Mont-Serrat, H, Kaiser, R, Misset, J L, Raymond, E
Format: Online
Language:English
Published: Nature Publishing Group 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242598/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242598/

Similar Items